In a study of 85 patients with AD, APOE ε4 homozygosity compared with heterozygosity was associated with significantly reduced post-mortem CSF melatonin (32pg/ml ± 8 vs 71 ± 7, p=0.02) [66]. Here, APOE is linked to Alzheimer disease.